BGL Announces New Partnership Between J-Pac Medical and Life Science Outsourcing

Brown Gibbons Lang & Company (BGL) is a leading investment banking and financial advisory firm, is pleased to announce a new partnership between J-Pac Medical (J-Pac), a leading manufacturing, packaging, and sterilization outsourcing partner based in Somersworth, NH, and Life Science Outsourcing (LSO). BGL’s Healthcare investment banking team initiated the transaction and acted as the exclusive financial advisor to J-Pac. The specific terms of the transaction were not disclosed.

Headquartered in Somersworth, NH, J-Pac has more than 35 years of experience providing innovative, high-quality, market-ready, and customized solutions to meet the needs of early-stage and established OEMs. J-Pac’s experience in complex thermoplastic devices, packaging, and in-house tooling capabilities allows it to manufacture anatomically correct, class III implantable textile assemblies, lab-on-chip reagent blisters, and complicated thermoformed packaging. As such, J-Pac has established a leading presence in the implantable medical textiles and diagnostics end-markets. J-Pac operates a 60,000 sq. ft. ISO 13485 certified and FDA registered facility with cleanroom capabilities in New Hampshire and has strong supplier relationships in Costa Rica. Further, J-Pac partners with its customers to offer effective onshore and managed nearshore solutions.

Founded in 1997 and located in Brea, CA, LSO is a leading FDA-registered and ISO 13485-certified full-service medical device contract manufacturer. LSO offers clients services including cleanroom assembly, packaging, sterilization, medical device manufacturing, medical package testing, sterilization validation, fulfillment & distribution, cleaning & decontamination, and quality incubator services.

The new partnership with J-Pac will allow LSO to provide a wider array of services to its customers across an even broader geographic footprint, further establishing it as a national platform that provides post-manufacturing and regulated services to early-stage and established players in the growing med-tech and diagnostics end-markets. This will provide a greater number of medical device and diagnostic organizations the opportunity to accelerate development and manufacturing capabilities.

BGL’s Healthcare & Life Sciences investment banking team is one of the most experienced and respected financial advisory teams in the U.S., with a long track record of expertise in advising medical device contract manufacturing companies, and in successfully advising outsourcing partners through strategic transactions.